Ubenimex enhances the antitumor effect of anti PD-1 antibody, regardless of the sensitivity of anti PD-1 antibody

被引：0

作者：

Igo, Naoko ^{[1
]}

Nagai, Daichi ^{[1
]}

Otake, Katsumasa ^{[1
]}

Tomura, Arihiro ^{[1
]}

Ichimura, Eiji ^{[1
]}

Yokoyama, Hirofumi ^{[1
]}

机构：

[1] Nippon Kayaku Co Ltd, Pharm Res Lab, Tokyo, Japan

来源：

CANCER SCIENCE | 2023年 / 114卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-2191

引用

页码：1178 / 1178

页数：1

共 50 条

[41] The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade [J].

Li, Howard Y. ;

McSharry, Maria ;

Bullock, Bonnie ;

Nguyen, Teresa T. ;

Kwak, Jeff ;

Poczobutt, Joanna M. ;

Sippel, Trisha R. ;

Heasley, Lynn E. ;

Weiser-Evans, Mary C. ;

Clambey, Eric T. ;

Nemenoff, Raphael A. .

CANCER IMMUNOLOGY RESEARCH, 2017, 5 (09) :767-777

[42] Identification and characterization of TSR-042, a novel anti-human PD-1 therapeutic antibody [J].

Laken, H. ;

Kehry, M. ;

McNeeley, P. ;

Neben, T. ;

Zhang, J. ;

Jenkins, D. ;

Wilcoxen, K. .

EUROPEAN JOURNAL OF CANCER, 2016, 69 :S102-S102

[43] Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review [J].

Li, Wei ;

Wang, Hao ;

Chen, Bin ;

Zhao, Sha ;

Zhang, Xiaoshen ;

Jia, Keyi ;

Deng, Juan ;

He, Yayi ;

Zhou, Caicun .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) :379-388

[44] Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naive and PD-1 antibody-experienced patients with melanoma (MEL64) [J].

Vavolizza, Rick Daniel ;

Petroni, Gina R. ;

Mauldin, Ileana S. ;

Chianese-Bullock, Kimberly A. ;

Olson, Walter C. ;

Smith, Kelly T. ;

Dengel, Lynn T. ;

Haden, Kathleen ;

Grosh, William W. ;

Kaur, Varinder ;

Varhegyi, Nikole ;

Gaughan, Elizabeth M. ;

Slingluff, Craig L., Jr. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)

[45] Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses [J].

Bu, Xia ;

Juneja, Vikram R. ;

Reynolds, Carol G. ;

Mahoney, Kathleen M. ;

Bu, Melissa T. ;

McGuire, Kathleen A. ;

Maleri, Seth ;

Hua, Ping ;

Zhu, Baogong ;

Klein, Sarah R. ;

Greenfield, Edward A. ;

Armand, Philippe ;

Ritz, Jerome ;

Sharpe, Arlene H. ;

Freeman, Gordon J. .

CANCER IMMUNOLOGY RESEARCH, 2021, 9 (12) :1465-1475

[46] The safety of anti PD-1 therapeutics for the treatment of melanoma [J].

Ramelyte, Egle ;

Schindler, Sabrina A. ;

Dummer, Reinhard .

EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) :41-53

[47] Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma [J].

Freimark, Bruce D. ;

Gong, Jian ;

Ye, Dan ;

Gray, Michael J. ;

Van Nguyen ;

Yin, Shen ;

Hatch, Michaela M. S. ;

Hughes, Christopher C. W. ;

Schroit, Alan J. ;

Hutchins, Jeff T. ;

Brekken, Rolf A. ;

Huang, Xianming .

CANCER IMMUNOLOGY RESEARCH, 2016, 4 (06) :531-540

[48] Fundamental effects of PD-1 antibody on the body: a brief report [J].

Wang, Wei ;

Liu, Bing ;

Liu, Guangxian ;

Guo, Wanfeng .

ONCOTARGETS AND THERAPY, 2016, 9 :4137-4141

[49] Radiotherapy enhances the effect of PD-1 checkpoint inhibitors [J].

Baumann, Rene ;

Dunst, Juergen .

STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) :763-764

[50] PD-1 suppresses antibody responses to Tn+ tumors [J].

Leyva, Marcela A. ;

Haas, Karen M. .

CANCER RESEARCH, 2015, 75

← 1 2 3 4 5 →